Managed Service Contract for the Provision of Secondary Blood Grouping & Sickle Cell Testing

NHSBT is looking to award a Managed Service Contract for the supply of commercially available automated blood group testing equipment for use as a secondary testing technology for ABO and Rh D typing, antibody screening and identification, extended red cell phenotyping and HbAS (heterozygous sickle cell trait) screening for donor blood, tissues and stem cell (haemopoietic progenitor cells and therapeutic cells) samples. Additional information: To express interest and participate in the tender, please register and a...